Ulcerative Colitis With Background Mucosal Inflammation Signals Poor Survival in Colorectal CancerJanuary 6, 2026Colon and Rectal
FDA OKs Subcutaneous Mosunetuzumab for Follicular LymphomaJanuary 6, 2026Lymphoma & Plasma Cell DisordersFDA Actions
Non-Operative Management Effective in Patients With Rectal Cancer Showing Clinical Complete Response to Neoadjuvant TherapyDecember 9, 2025Colon and Rectal
